Nasdaq:US$15.81 (+0.12) | HKEX:HK$25.20 (+0.00) | AIM:£2.30 (+0.09)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702